Ingrid Glimelius

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Jag är överläkare i Onkologi och arbetar med patienter som har drabbats av lymfom eller testikelcancer. Jag arbetar som läkare på onkologkliniken, Akademiska Sjukhuset Uppsala. Utöver detta bedriver jag forskningsstudier med syfte att förbättra för de som drabbats av dessa cancersjukdomar. Sedan 2002 har jag varit involverad i lymfomforskning och sedan 2011 har jag samarbetat med Karin Ekström Smedby (https://ki.se/people/kariek [1]) och varit anknuten till cancerepidemiologigruppen vid Enheten för Klinisk Epidemiologi, Karolinska Institutet. Utöver mitt kliniska arbete är jag ansvarig för kliniska fas I-III studier, epidemiologiska studier och handleder doktorander. Jag har ett stort intresse för undervisning och undervisar både läkarstudenter och blivande specialistläkare Leg Läkare, Uppsala Universitet 2001 PHD, Uppsala Universitet 2009, Avhandling: /Hodgkin lymphoma – an interplay between tumour cell and microenvironment./ Specialist Internmedicin 2011 Specialist Onkologi 2013 Docent i Onkologi 2016 Good Clinical Practice, Investigator Site Personnel ICH-GCP Överläkare Onkologi 2019 Lektor Uppsala Universitet 2021- [1] https://ki.se/people/kariek

Forskningsbeskrivning

En beskrivning av min forskning finns på den engelskspråkiga sidan https://ki.se/en/people/inggli [1]. [1] https://ki.se/en/people/inggli

Undervisning

Jag undervisar på läkarutbildningen och handleder regelbundet läkarstudenter samt blivande specialistläkare framförallt om orsak, diagnostik, behandling och omhändertagande av patienter med olika lymfatiska maligniteter. Kursanvarig läkarutbildningen i Onkologi Uppsala Universitet 2012 Högskolepedagogisk Grundkurs 2014 Good Clinical Practice, Investigator Site Personnel ICH-GCP Examinator projektarbeten läkarutbildningen Uppsala Universitet, sedan 2017- Bred undervisningserfarenhet på både grund och specialiserad nivå Styrgruppen för Nationella Forskar Skolan i Onkologi, NATION 2019- Immunterapi och tumörens mikromiljö, kursansvarig 2019-

Artiklar

Journal article: ANNALS OF ONCOLOGY. 2024;35(3):245-247

Hit hard and remove treatment - this treatment strategy in Hodgkin Lymphoma promises less fatigue and less sick-leave.

Glimelius I
Article: JOURNAL OF CANCER SURVIVORSHIP. 2024;:1-11

Long-term prescribed drug use in stage I-III rectal cancer patients in Sweden, with a focus on bowel-regulating drugs after surgical and oncological treatment.

Boman SE; Fuentes S; Nordenvall C; Martling A; Chen L; Glimelius I; Neovius M; Smedby KE; Eloranta S
Article: BJU INTERNATIONAL. 2024

Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours.

Gerdtsson A; Negaard HFS; Almås B; Bergdahl AG; Cohn-Cedermark G; Glimelius I; Halvorsen D; Haugnes HS; Hedlund A; Hellström M; Holmberg G; Karlsdóttir Á; Kjellman A; Larsen SM; Thor A; Wahlqvist R; Ståhl O; Tandstad T
Article: BLOOD ADVANCES. 2024;8(2):407-415

MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial.

Jerkeman M; Kolstad A; Hutchings M; Pasanen A; Meriranta L; Niemann CU; Kragh Jørgensen RR; El-Galaly TC; Riise J; Leppä S; Christensen JH; Sonnevi K; Pedersen LB; Wader KF; Glimelius I
Journal article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2023;52(6):1826-1835

Cancer risk in the siblings of individuals with major birth defects: a large Nordic population-based case-control study.

Daltveit DS; Klungsøyr K; Engeland A; Ekbom A; Gissler M; Glimelius I; Grotmol T; Madanat-Harjuoja L; Ording AG; Sørensen HT; Troisi R; Bjørge T
Journal article: CANCER CAUSES & CONTROL. 2023;:1-7

Associations between pregnancy-related factors and birth characteristics with risk of rare uterine cancer subtypes: a Nordic population-based case-control study.

Abril J; Trabert B; Troisi R; Grotmol T; Ekbom A; Engeland A; Gissler M; Glimelius I; Madanat-Harjuoja L; Gulbech Ording A; Sørensen HT; Tretli S; Bjørge T
Journal article: ACTA ONCOLOGICA. 2023;62(12):1707-1715

Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2.

Ginman B; Pahnke S; Freyhult E; Hoffman T; Kolstad L; Rönnberg B; Lundkvist Å; Hamberg Levedahl K; Enblad G; Glimelius I
Article: EUROPEAN JOURNAL OF CANCER. 2023;195:113403

Secondary malignancies among mantle cell lymphoma patients.

Abalo KD; Smedby KE; Ekberg S; Eloranta S; Pahnke S; Albertsson-Lindblad A; Jerkeman M; Glimelius I
Journal article: BLOOD. 2023;142:1656

An International Multicohort Study of Conditional Survival and Cause of Death after Achieving Event-Free Survival at 24 Months in Patients with Mantle Cell Lymphoma

Wang Y; Larson MC; Farooq U; Ekberg S; Smedby KE; Simonsen MR; Niemann CU; Zhao EJ; Gerrie AS; Switchenko JM; Bond DA; Bachanova V; Barta SK; Hill BT; Martin P; Danilov A; Grover NS; Karmali R; Ghosh N; Fenske TS; Kahl BS; Albertsson-Lindblad A; Glimelius IC; Al-Mashhadi AL; Larsen TS; Maddocks KJ; Link BK; Paludo J; Nowakowski GS; Habermann TM; Maurer MJ; Villa D; Cohen JB; El-Galaly TCC; Jerkeman M; Cerhan JR
Journal article: BLOOD. 2023;142(Supplement 1):1729

Mitigating the Risk of Cytokine Release Syndrome (CRS): Preliminary Results from a DLBCL Cohort of Epcore NHL-1

Vose JM; Feldman T; Chamuleau MED; Kim WS; Lugtenburg P; Kim TM; Costa PA; Cheah CY; Glimelius IC; Hess B; Jurczak W; Musuraca G; Olszewski AJ; Dinh M; Kilavuz N; Wielgos-Bonvallet M; Li T; Li Z; Eskelund C; Farooq U
Article: BRITISH JOURNAL OF CANCER. 2023;128(12):2261-2269

Risk and mortality of testicular cancer in patients with neurodevelopmental or other psychiatric disorders.

Jansson AK; Söderling J; Reutfors J; Thor A; Sköld C; Cohn-Cedermark G; Ståhl O; Smedby KE; Pettersson A; Glimelius I
Journal article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2023;52(3):966

Correction to: Sex differences in childhood cancer risk among children with major birth defects: a Nordic population-based nested case-control study.
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41(S2):472-474

Multicohort Study of Conditional Survival and Cause of Death After Achieving Event‐Free Survival at 24 Months (EFS24) in Patients With Mantle Cell Lymphoma (MCL)

Wang Y; Larson MC; Ekberg S; Smedby KE; Zhao EJ; Gerrie AS; Farooq U; Maurer MJ; Paludo J; Nowakowski GS; Habermann TM; Albertsson‐Lindblad A; Glimelius I; Link BK; Diego V; Jerkeman M; Cerhan JR
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16_suppl):5008

Primary retroperitoneal lymph node dissection (RPLND) in seminoma stage IIA-IIC ≤3cm: Combined results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) and Cologne.

Tandstad T; Kjellman A; Almås B; Grenabo Bergdahl A; Cohn-Cedermark GE; Gerdtsson A; Glimelius I; Halvorsen DL; Haugnes HSS; Hedlund A; Karlsdottir A; Larsen SM; Negaard HFS; Pfister D; Stahl O; Thor A; Wahlquist R; Heidenreich A; Paffenholz P; Seelemeyer F
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41(S2):471-472

Timing of disease progression and impact on survival in Swedish mantle cell lymphoma patients—a novel illness‐death model study

Ekberg S; Glimelius I; Albertsson‐Lindblad A; Weibull CE
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41(S2):475-476

Secondary malignancies in mantle cell lymphoma patients—A nationwide population‐based study in Sweden

Abalo K; Smedby KE; Ekberg S; Eloranta S; Pahnke S; Albertsson‐Lindblad A; Jerkeman M; Glimelius I
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41(S2):746-748

SOLUBLE MACROPHAGE MARKER SCD163 PREDICTS OUTCOME IN BOTH CHEMOIMMUNOTHERAPY AND TARGETED THERAPY TREATED MANTLE CELL LYMPHOMA

Nikkarinen A; Lokhande L; Amini R; Jerkeman M; Porwit A; Molin D; Enblad G; Kolstad A; Räty R; Hutchings M; Weibull CE; Hollander P; Ek S; Glimelius I
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41(S2):477-478

Enhanced ctDNA Profiling Reveals Molecular Determinants of Response and Resistance in Relapsed and Refractory Mantle Cell Lymphoma (NLG‐MCL7‐VALERIA)

Meriranta L; Kolstad A; Hutchings M; Pasanen A; Niemann CU; Riise J; Christensen JH; Wader KF; Glimelius I; Leppä S; Jerkeman M
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41(S2):369-370

Secondary cancer is the leading cause of death 15 years or more after diagnosis of early‐stage Hodgkin lymphoma

Lagerlöf I; Fohlin H; Enblad G; Glimelius B; Goldkuhl C; Palma M; Glimelius I; Molin D
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16_suppl):tps7595

waveLINE-006: A phase 2 study of the safety and efficacy of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B-cell malignancies.

Zinzani PL; Mayer J; Benjamini O; Berkovits A; Glimelius I; Stevens DA; Chaudhry A; Muzaffer Demir A; Garcia Sanz R; Seog Kim W; Li F; Halka J; Marin-Niebla A; Ozcan M; Paszkiewicz-Kozik E; Santoro A; Ren Y; Ogbu U; Marinello P; Jurczak W
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41(S2):476-477

How to choose between curative radiotherapy or chemotherapy in low stage MCL?—a population‐based analysis of outcome in patients with stage I‐II MCL in Sweden

Albertsson‐Lindblad A; Ekberg S; Glimelius I; Ellin F; Sonnevi K; Lewerin C; Smedby KE; Jerkeman M
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41(S2):474-475

Outcomes of younger patients with mantle‐cell lymphoma experiencing late relapse (>24 months): the LATE‐POD study

Visco C; Malinverni C; Florea E; Glimelius I; Mirandola M; Ekström‐Smedby K; Tisi MC; Giné E; Albertsson‐Lindblad A; Niebla AM; Di Rocco A; Moita F; Sciarra R; Bašić‐Kinda S; Hess G; Ohler A; Eskelund C; Re A; Ferrarini I; Kolstad A; Räty R; Quaglia FM; Bernardelli A; Eyre TA; Scapinello G; Stefani PM; Morello L; Nassi L; Hohaus S; Ragaini S; Zilioli VR; Bruna R; Cocito F; Arcari A; Jerkeman M
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2023;32(5):687-696

Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies.

Argirion I; Pfeiffer RM; Proietti C; Coghill AE; Yu KJ; Middeldorp JM; Sarathkumara YD; Hsu W-L; Chien Y-C; Lou P-J; Wang C-P; Rothman N; Lan Q; Chen C-J; Mbulaiteye SM; Jarrett RF; Glimelius I; Smedby KE; Hjalgrim H; Hildesheim A; Doolan DL; Liu Z
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2023;52(2):450-465

Sex differences in childhood cancer risk among children with major birth defects: a Nordic population-based nested case-control study.

Daltveit DS; Klungsøyr K; Engeland A; Ekbom A; Gissler M; Glimelius I; Grotmol T; Madanat-Harjuoja L; Ording AG; Sørensen HT; Troisi R; Bjørge T
Article: BLOOD ADVANCES. 2023;7(5):866-874

Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation.

Ekberg S; Smedby KE; Albertsson-Lindblad A; Jerkeman M; Weibull CE; Glimelius I
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2023;192(1):70-83

Maternal Health, Pregnancy and Offspring Factors, and Maternal Thyroid Cancer Risk: A Nordic Population-Based Registry Study.

Kitahara CM; Slettebø Daltveit D; Ekbom A; Engeland A; Gissler M; Glimelius I; Grotmol T; Trolle Lagerros Y; Madanat-Harjuoja L; Männistö T; Sørensen HT; Troisi R; Bjørge T
Journal article: HEMASPHERE. 2022;6(Suppl ):42

P091: Early analysis of the PRO-Hodgkin study: Clinical investigation of pencil beam scanning proton treatment in Hodgkin lymphoma patients

Goldkuhl C; Dasu A; Bäck A; Enblad G; Glimelius I; Hall A; Hansson L; Jerlström. U; Johansson A-S; Kahlmeter-Brandell J; Linderoth J; Palma M; Rylander H; Enmark M; Molin D
Journal article: HEMASPHERE. 2022;6(Suppl ):37-38

T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients

Övergaard N; Lia K; Asdahl P; Wikman P; Glimelius I; Lagerlöf. I; Johansson A-S; Hansson L; Enblad G; Linderoth J; Goldkuhl C; Fosså A; Kamper P; Molin D
Journal article: HEMASPHERE. 2022;6(Suppl ):37

P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival

Baech J; Jakobsen LH; El-Galaly TC; Molin D; Glimelius I; Entrop JP; Crowther MJ; Smedby KE; Eloranta S; Weibull CE
Journal article: HEMASPHERE. 2022;6(Suppl ):30

T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway

Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; øvlisen AK; Molin D; Glimelius I; Marklund A; Holte H; Fosså A; Smeland KB; El-Galaly TC; Eloranta S
Journal article: HEMASPHERE. 2022;6(Suppl ):44

P096: Polymorphisms in SETD7 may predispose the risk of developing late cardiac side effects after radiotherapy including the mediastinum in Hodgkin’ s lymphoma.

Linderoth J; Freyhult E; Andreasson E; Johansson A-S; Andersson A; Glimelius I; Enblad G; Molin D
Journal article: ANNALS OF ONCOLOGY. 2022;33:s1197-s1198

1427P The role of anxiety and self-isolation in seropositivity for COVID-19 in actively treated cancer patients in Sweden

Ginman B; Pahnke S; Freyhult E; Hoffman T; Kolstad L; Rönnberg B; Lundkvist Å; Hamberg K; Enblad G; Glimelius I
Journal article: HEMASPHERE. 2022;6:103-104

S202: CHILDBEARING AMONG CLASSICAL HODGKIN LYMPHOMA SURVIVORS TREATED WITH BEACOPP AND ABVD IN SWEDEN, DENMARK, AND NORWAY

Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; Øvlisen AK; Molin D; Glimelius I; Marklund A; Smeland KB; El‐Galaly TC; Eloranta S
Journal article: HEMASPHERE. 2022;6(Suppl):983-984

P1093: A NEW PROGNOSTIC MODEL FOR INDIVIDUAL OUTCOME PREDICTION IN ADVANCED‐STAGE HODGKIN LYMPHOMA.

Jørgensen RRK; Eloranta S; Severinsen MT; Øvlisen AK; Smeland KB; Kiserud C; Christensen JH; Hutchings M; Sørensen RB; Kamper P; Glimelius I; Smedby KE; Bergström F; El‐Galaly TC; Jakobsen LH
Journal article: CANCER RESEARCH. 2022;82(12_Supplement):2026

Abstract 2026: Spatially resolved multiplexed analysisreveals how macrophages adapt to the mantle cell lymphoma microenvironment

Rodrigues JM; Lokhande L; Gerdtsson A; Nikkarinen A; Hollander P; Porwit A; Glimelius I; Jerkeman M; Ek S
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;197(5):580-589

Checkpoint CD47 expression in classical Hodgkin lymphoma.

Gholiha AR; Hollander P; Löf L; Glimelius I; Hedstrom G; Molin D; Hjalgrim H; Smedby KE; Hashemi J; Amini R-M; Enblad G
Article: JOURNAL OF CLINICAL ONCOLOGY. 2022;40(13):1487-1496

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.

Lagerlöf I; Fohlin H; Enblad G; Glimelius B; Goldkuhl C; Palma M; Åkesson L; Glimelius I; Molin D
Article: EUROPEAN UROLOGY ONCOLOGY. 2022;5(2):235-243

Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group.

Gerdtsson A; Thor A; Grenabo Bergdahl A; Almås B; Håkansson U; Törnblom M; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Sagstuen Haugnes H; Engen Andreassen K; Melsen Larsen S; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
Article: INTERNATIONAL JOURNAL OF CANCER. 2022;150(5):773-781

Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes.

Sköld C; Koliadi A; Enblad G; Stålberg K; Glimelius I
Article: BLOOD CANCER JOURNAL. 2022;12(1):16

Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark.

Jakobsen LH; Øvlisen AK; Severinsen MT; Bæch J; Kragholm KH; Glimelius I; Gang AO; Jørgensen JM; Frederiksen H; Poulsen CB; Clausen MR; Pedersen PT; Pedersen RS; Torp-Pedersen C; Eloranta S; El-Galaly TC
Journal article: BLOOD. 2021;138:1344

Late Effects after Treatment in Mantle Cell Lymphoma: No Difference By Intensity of First-Line Regimens with or without Autologous Stem Cell Transplantation

Ekberg S; Smedby KE; Albertsson-Lindblad A; Jerkeman M; Weibull C; Glimelius I
Article: ACTA ONCOLOGICA. 2021;60(11):1459-1465

Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study.

Ullgren H; Camuto A; Rosas S; Pahnke S; Ginman B; Enblad G; Glimelius I; Fransson P; Friesland S; Liu LL
Article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(31):3463-3472

Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study.

Øvlisen AK; Jakobsen LH; Eloranta S; Kragholm KH; Hutchings M; Frederiksen H; Kamper P; Dahl-Sørensen RB; Stoltenberg D; Weibull CE; Entrop JP; Glimelius I; Smedby KE; Torp-Pedersen C; Severinsen MT; El-Galaly TC
Article: EJHAEM. 2021;2(3):400-412

Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years.

Wahlin BE; Övergaard N; Peterson S; Digkas E; Glimelius I; Lagerlöf I; Johansson A-S; Palma M; Hansson L; Linderoth J; Goldkuhl C; Molin D
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;193(5):906-914

Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study.

Abu Sabaa A; Mörth C; Hasselblom S; Hedström G; Flogegård M; Stern M; Andersson P-O; Glimelius I; Enblad G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;193(3):520-531

Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors.

Rodrigues JM; Nikkarinen A; Hollander P; Weibull CE; Räty R; Kolstad A; Amini R-M; Porwit A; Jerkeman M; Ek S; Glimelius I
Article: BLOOD ADVANCES. 2021;5(6):1671-1681

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma.

Gholiha AR; Hollander P; Glimelius I; Hedstrom G; Molin D; Hjalgrim H; Smedby KE; Hashemi J; Amini R-M; Enblad G
Article: BLOOD ADVANCES. 2021;5(6):1638-1647

Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival.

Glimelius I; Smedby KE; Albertsson-Lindblad A; Crowther MJ; Eloranta S; Jerkeman M; Weibull CE
Article: LANCET DIABETES & ENDOCRINOLOGY. 2021;9(2):94-105

Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study.

Kitahara CM; Slettebø Daltveit D; Ekbom A; Engeland A; Gissler M; Glimelius I; Grotmol T; Trolle Lagerros Y; Madanat-Harjuoja L; Männistö T; Sørensen HT; Troisi R; Bjørge T
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(3):551-559

Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study.

Wästerlid T; Oren Gradel K; Eloranta S; Glimelius I; El-Galaly TC; Frederiksen H; Smedby KE
Article: HEMASPHERE. 2021;5(1):e510

Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3.

Eskelund CW; Dimopoulos K; Kolstad A; Glimelius I; Räty R; Gjerdrum LMR; Sonnevi K; Josefsson P; Nilsson-Ehle H; Bentzen HHN; Fagerli UM; Kuittinen O; Haaber J; Niemann CU; Pedersen LB; Larsen MT; Geisler CH; Hutchings M; Jerkeman M; Grønbæk K
Article: BMJ-BRITISH MEDICAL JOURNAL. 2020;371:m4060

Cancer risk in individuals with major birth defects: large Nordic population based case-control study among children, adolescents, and adults.

Daltveit DS; Klungsøyr K; Engeland A; Ekbom A; Gissler M; Glimelius I; Grotmol T; Madanat-Harjuoja L; Ording AG; Sæther SMM; Sørensen HT; Troisi R; Bjørge T
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;191(5):796-805

p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma.

Rodrigues JM; Hassan M; Freiburghaus C; Eskelund CW; Geisler C; Räty R; Kolstad A; Sundström C; Glimelius I; Grønbaek K; Kwiecinska A; Porwit A; Jerkeman M; Ek S
Journal article: BLOOD. 2020;136:15

Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - Data from the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase I Trial: Stopping Treatment in Molecular Remission Is Feasible

Jerkeman M; Kolstad A; Niemann CU; Groenbaek K; Hutchings M; Pasanen A; Ekberg S; Wader KF; Glimelius I
Article: ACTA ONCOLOGICA. 2020;59(8):949-958

Birthweight and all-cause mortality after childhood and adolescent leukemia: a cohort of children with leukemia from Denmark, Norway, Sweden, and Washington State.

Ording AG; Christensen LB; Bjørge T; Doody DR; Ekbom A; Glimelius I; Grotmol T; Larfors G; Mueller BA; Smedby KE; Tretli S; Troisi R; Sørensen HT
Article: BRITISH JOURNAL OF CANCER. 2020;123(1):161-166

Pregnancy-related risk factors for sex cord-stromal tumours and germ cell tumours in parous women: a registry-based study.

Sköld C; Bjørge T; Ekbom A; Engeland A; Gissler M; Grotmol T; Madanat-Harjuoja L; Ording AG; Trabert B; Tretli S; Troisi R; Sørensen HT; Glimelius I
Article: EJHAEM. 2020;1(1):199-207

Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival.

Persson Skare T; Sjöberg E; Berglund M; Smith RO; Roche FP; Lindskog C; Sander B; Glimelius I; Gholiha AR; Enblad G; Amini R-M; Claesson-Welsh L
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(6):1083-1092

Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register study.

Ekberg S; E Smedby K; Glimelius I; Nilsson-Ehle H; Goldkuhl C; Lewerin C; Jerkeman M; Eloranta S
Article: EUROPEAN UROLOGY ONCOLOGY. 2020;3(3):382-389

Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.

Gerdtsson A; Håkansson U; Törnblom M; Jancke G; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(1):106-116

Comorbidities and sex differences in causes of death among mantle cell lymphoma patients - A nationwide population-based cohort study.

Glimelius I; Smedby KE; Eloranta S; Jerkeman M; Weibull CE
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;146(6):1523-1531

Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: A Nordic population-based case-control study.

Trabert B; Troisi R; Grotmol T; Ekbom A; Engeland A; Gissler M; Glimelius I; Madanat-Harjuoja L; Sørensen HT; Tretli S; Gulbech Ording A; Bjørge T
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;188(5):685-691

No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.

Lagerlöf I; Holte H; Glimelius I; Björkholm M; Enblad G; Erlanson M; Fluge Ø; Fohlin H; Fosså A; Goldkuhl C; Gustavsson A; Johansson A-S; Linderoth J; Nome O; Palma M; Åkesson L; Østenstad B; Raud C; Glimelius B; Molin D
Article: IMMUNOBIOLOGY. 2020;225(1):151872

Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma.

Hollander P; Ginman B; Molin D; Enblad G; Amini R-M; Glimelius I
Article: INTERNATIONAL JOURNAL OF CANCER. 2019;145(5):1200-1208

Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients.

Weibull CE; Björkholm M; Glimelius I; Lambert PC; Andersson TML; Smedby KE; Dickman PW; Eloranta S
Article: CANCER MEDICINE. 2019;8(10):4918-4927

Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors-A population-based cohort study from Sweden and Denmark.

Glimelius I; Englund A; Rostgaard K; Smedby KE; Eloranta S; de Nully Brown P; Johansen C; Kamper P; Ljungman G; Hjalgrim LL; Hjalgrim H
Article: PLOS MEDICINE. 2019;16(6):e1002816

Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study.

Al-Jebari Y; Glimelius I; Berglund Nord C; Cohn-Cedermark G; Ståhl O; Tandstad T; Jensen A; Sagstuen Haugnes H; Daugaard G; Rylander L; Giwercman A
Journal article: HEMASPHERE. 2019;3(S1):141-142

PF379 PREVALENCE AND INCIDENCE OF CARDIOVASCULAR DISEASE IN CHRONIC LYMPHOCYTIC LEUKEMIA: A NATION‐WIDE POPULATION‐BASED STUDY

Larsson K; Mattsson M; Ebrahim F; Glimelius I; Höglund M
Journal article: HEMATOLOGICAL ONCOLOGY. 2019;37(S2):242

EARLY PROGRESSION OF MANTLE CELL LYMPHOMA DEPICTS A HIGH‐RISK DISEASE WITH POOR RESPONSE TO SUBSEQUENT THERAPIES AND A DISMAL OUTCOME

Eskelund CW; Kolstad A; Glimelius I; Räty R; Gjerdrum LR; Sonnevi K; Josefsson P; Nilsson‐Ehle H; Bentzen H; Fagerli U; Kuittinen O; Haaber J; Pedersen LB; Larsen MT; Geisler CH; Hutchings M; Jerkeman M; Grønbæk K
Article: JOURNAL OF INTERNAL MEDICINE. 2019;285(4):455-468

Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study.

Wästerlid T; Mohammadi M; Smedby KE; Glimelius I; Jerkeman M; Bottai M; Eloranta S
Article: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(9):703-713

Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study.

Biccler JL; Glimelius I; Eloranta S; Smeland KB; Brown PDN; Jakobsen LH; Frederiksen H; Jerkeman M; Fosså A; Andersson TML; Holte H; Bøgsted M; El-Galaly TC; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2019;184(2):192-201

High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms.

Gholiha AR; Hollander P; Hedstrom G; Sundstrom C; Molin D; Smedby KE; Hjalgrim H; Glimelius I; Amini R-M; Enblad G
Article: INTERNATIONAL JOURNAL OF CANCER. 2018;143(8):1904-1913

Pregnancy complications and subsequent breast cancer risk in the mother: a Nordic population-based case-control study.

Troisi R; Gulbech Ording A; Grotmol T; Glimelius I; Engeland A; Gissler M; Trabert B; Ekbom A; Madanat-Harjuoja L; Sørensen HT; Tretli S; Bjørge T
Article: INTERNATIONAL JOURNAL OF CANCER. 2018;143(8):1858-1867

Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women.

Sköld C; Bjørge T; Ekbom A; Engeland A; Gissler M; Grotmol T; Madanat-Harjuoja L; Gulbech Ording A; Stephansson O; Trabert B; Tretli S; Troisi R; Sørensen HT; Glimelius I
Article: JOURNAL OF CLINICAL ONCOLOGY. 2018;36(26):2718-2725

Contemporarily Treated Patients With Hodgkin Lymphoma Have Childbearing Potential in Line With Matched Comparators.

Weibull CE; Johansson ALV; Eloranta S; Smedby KE; Björkholm M; Lambert PC; Dickman PW; Glimelius I
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;101(1):106-114

Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma-A population-based study from Sweden.

Björkholm M; Weibull CE; Eloranta S; Smedby KE; Glimelius I; Dickman PW
Article: JOURNAL OF INTERNAL MEDICINE. 2018;283(5):430-445

The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence.

Troisi R; Bjørge T; Gissler M; Grotmol T; Kitahara CM; Myrtveit Saether SM; Ording AG; Sköld C; Sørensen HT; Trabert B; Glimelius I
Article: RADIOTHERAPY AND ONCOLOGY. 2018;126(3):424-430

Short- and long-term risks of cardiovascular disease following radiotherapy in rectal cancer in four randomized controlled trials and a population-based register.

Chen L; Eloranta S; Martling A; Glimelius I; Neovius M; Glimelius B; Smedby KE
Article: ACTA ONCOLOGICA. 2018;57(2):276-282

Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome.

Englund A; Glimelius I; Rostgaard K; Smedby KE; Eloranta S; Molin D; Kuusk T; Brown PDN; Kamper P; Hjalgrim H; Ljungman G; Hjalgrim LL
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(1):88-97

An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.

Hollander P; Rostgaard K; Smedby KE; Molin D; Loskog A; de Nully Brown P; Enblad G; Amini R-M; Hjalgrim H; Glimelius I
Article: PLOS ONE. 2018;13(9):e0204870

Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma.

Hollander P; Amini R-M; Ginman B; Molin D; Enblad G; Glimelius I
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;186(10):1159-1167

Parental Age and Risk of Lymphoid Neoplasms.

Larfors G; Glimelius I; Eloranta S; Smedby KE
Article: BLOOD ADVANCES. 2017;1(18):1427-1439

High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome.

Hollander P; Kamper P; Smedby KE; Enblad G; Ludvigsen M; Mortensen J; Amini R-M; Hamilton-Dutoit S; d'Amore F; Molin D; Glimelius I
Journal article: HEMATOLOGICAL ONCOLOGY. 2017;35(S2):100-101

UNMET MEDICAL NEEDS IN HODGKIN LYMPHOMA WITH SPECIAL FOCUS ON THE ELDERLY – a POPULATION‐BASED STUDY OF PATIENTS DIAGNOSED IN SWEDEN 1973‐2014

Bjorkholm M; Weibull CE; Eloranta S; Ekström‐Smedby K; Glimelius I; Dickman PW
Journal article: HEMATOLOGICAL ONCOLOGY. 2017;35(S2):172-173

MORTALITY RATES REMAIN INCREASED IN YOUNG PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA EVEN AFTER YEARS IN REMISSION: RESULTS FROM A NORDIC LYMPHOMA GROUP STUDY

Biccler J; Glimelius I; Eloranta S; de Nully Brown P; Jakobsen LH; Frederiksen H; Jerkeman M; Bøgsted M
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;185(8):681-687

Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma.

Baecklund F; Foo J-N; Askling J; Eloranta S; Glimelius I; Liu J; Hjalgrim H; Rosenquist R; Padyukov L; Smedby KE
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2017;92(3):251-258

Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy.

Glimelius I; Eloranta S; Ekberg S; Chang ET; Neovius M; Smedby KE
Article: BRITISH JOURNAL OF CANCER. 2016;115(11):1416-1420

Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case-control study.

Bjørge T; Gissler M; Ording AG; Engeland A; Glimelius I; Leinonen M; Sørensen HT; Tretli S; Ekbom A; Troisi R; Grotmol T
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2016;97(5):430-438

The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children.

Englund A; Molin D; Enblad G; Karlén J; Glimelius I; Ljungman G; Amini R-M
Article: LEUKEMIA & LYMPHOMA. 2016;57(10):2351-2358

Association between HLA-A1 and -A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder.

Kinch A; Sundström C; Tufveson G; Glimelius I
Article: JOURNAL OF CANCER SURVIVORSHIP. 2016;10(3):514-523

Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse.

Everhov ÅH; Ekberg S; Hirschberg AL; Bergmark K; Rådestad AF; Glimelius I; Smedby KE
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2016;25(6):987-994

Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss.

Chen L; Glimelius I; Neovius M; Ekberg S; Martling A; Eloranta S; Smedby KE
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2016;51(5):583-589

Risk of lymphoid neoplasms in a Swedish population-based cohort of 337,437 patients undergoing appendectomy.

Mohammadi M; Song H; Cao Y; Glimelius I; Ekbom A; Ye W; Smedby KE
Article: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(4):337-344

Pregnancy and the Risk of Relapse in Patients Diagnosed With Hodgkin Lymphoma.

Weibull CE; Eloranta S; Smedby KE; Björkholm M; Kristinsson SY; Johansson ALV; Dickman PW; Glimelius I
Article: JOURNAL OF CANCER SURVIVORSHIP. 2015;9(4):599-609

Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study.

Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2015;24(12):1838-1843

A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma.

Delahaye-Sourdeix M; Urayama KY; Gaborieau V; Veenstra R; Foll M; Chabrier A; Benavente Y; Nieters A; Becker N; Foretova L; Maynadié M; Staines A; Smedby KE; Glimelius I; Lightfoot T; Cocco P; Galan P; Vatten LJ; Duell EJ; Kiemeney L; Roman E; de Sanjosé S; Lathrop M; Melbye M; Brennan P; Diepstra A; van den Berg A; Hjalgrim H; Jarrett RF; McKay JD
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2015;90(12):1128-1134

Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics.

Glimelius I; Ekberg S; Jerkeman M; Chang ET; Björkholm M; Andersson TML; Smedby KE; Eloranta S
Article: ACTA ONCOLOGICA. 2015;54(10):1770-1780

Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment.

Nord C; Olofsson S-E; Glimelius I; Cedermark GC; Ekberg S; Cavallin-Ståhl E; Neovius M; Jerkeman M; Smedby KE
Article: BMC CANCER. 2015;15:850

The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.

Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2015;182(7):624-632

Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma.

Hollander P; Rostgaard K; Smedby KE; Chang ET; Amini R-M; de Nully Brown P; Glimelius B; Adami H-O; Melbye M; Glimelius I; Hjalgrim H
Article: BRITISH JOURNAL OF SURGERY. 2015;102(11):1426-1432

Risk of disability pension in patients following rectal cancer treatment and surgery.

Chen L; Glimelius I; Neovius M; Eloranta S; Ekberg S; Martling A; Smedby KE
Article: BLOOD. 2013;122(20):3492-3499

Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis.

Monnereau A; Glaser SL; Schupp CW; Ekström Smedby K; de Sanjosé S; Kane E; Melbye M; Forétova L; Maynadié M; Staines A; Becker N; Nieters A; Brennan P; Boffetta P; Cocco P; Glimelius I; Clavel J; Hjalgrim H; Chang ET
Article: HISTOPATHOLOGY. 2012;61(1):26-32

Tissue microarray and digital image analysis: a methodological study with special reference to the microenvironment in Hodgkin lymphoma.

Glimelius I; Qvarnström F; Simonsson M; Ekwall A; Smedby KE; Molin D; Amini R-M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2011;87(3):208-216

Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's lymphoma--a population-based study.

Glimelius I; Rubin J; Rostgaard K; Amini R-M; Simonsson M; Sorensen KM; Smedby KE; Venge P; Hjalgrim H; Molin D; Enblad G
Article: EXPERIMENTAL HEMATOLOGY. 2011;39(8):850-858

Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines.

Glimelius I; Rubin J; Fischer M; Molin D; Amini R-M; Venge P; Enblad G
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2008;67(1):53-56

Expression of mast cell tryptases in Hodgkin and Reed-Sternberg (HRS) cells.

Carvalho RFS; Mahshid Y; Claesson H-E; Glimelius I; Fischer M; Nilsson G
Article: HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. 2007;21(5):805-823

The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma.

Enblad G; Molin D; Glimelius I; Fischer M; Nilsson G
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2006;76(4):278-283

IL-9 expression contributes to the cellular composition in Hodgkin lymphoma.

Glimelius I; Edström A; Amini R-M; Fischer M; Nilsson G; Sundström C; Enblad G; Molin D
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2003;71(5):327-333

Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB.

Glimelius I; Molin D; Amini R-M; Gustavsson A; Glimelius B; Enblad G
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2003;290(4):465-475

Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.

Travis LB; Hill DA; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Wiklund T; Lynch CF; Van't Veer MB; Glimelius I; Storm H; Pukkala E; Stovall M; Curtis R; Boice JD; Gilbert E
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;119(1):122-124

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma.

Molin D; Edström A; Glimelius I; Glimelius B; Nilsson G; Sundström C; Enblad G
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2002;94(3):182-192

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.

Travis LB; Gospodarowicz M; Curtis RE; Clarke EA; Andersson M; Glimelius B; Joensuu T; Lynch CF; van Leeuwen FE; Holowaty E; Storm H; Glimelius I; Pukkala E; Stovall M; Fraumeni JF; Boice JD; Gilbert E
Visa fler

Alla övriga publikationer

Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16)

Primary retroperitoneal lymph node dissection (RPLND) in seminoma stage IIA-IIC ≤3cm: Combined results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) and Cologne

Tandstad T; Kjellman A; Almas B; Bergdahl AG; Cohn-Cedermark GE; Gerdtsson A; Glimelius I; Halvorsen DL; Haugnes HSS; Hedlund A; Karlsdottir A; Larsen SM; Negaard HFS; Pfister D; Stahl O; Thor A; Wahlquist R; Heidenreich A; Paffenholz P; Seelemeyer F
Conference publication: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2023;23:S457-S458

Multicohort Study of Conditional Survival and Cause of Death After Achieving Event-Free Survival at 24 Months (EFS24) in Patients With Mantle Cell Lymphoma (MCL)

Wang Y; Larson M; Ekberg S; Smedby K; Zhao E; Gerrie A; Farooq U; Maurer M; Paludo J; Nowakowski G; Habermann T; Albertsson-Lindblad A; Glimelius I; Link B; Villa D; Jerkeman M; Cerhan J
Conference publication: AMERICAN JOURNAL OF HEMATOLOGY. 2023;98:S51-S52

Zilovertamab Vedotin Alone or in Combination With Nemtabrutinib in Aggressive and Indolent B-Cell Malignancies: Phase 2waveLINE-006Study

Zinzani PL; Mayer J; Benjamini O; Berkovits A; Glimelius I; Stevens D; Chaudhry A; Demir AM; Garcia Sanz R; Kim WS; Li F; Halka J; Marin-Niebla A; Ozcan M; Paszkiewicz-Kozik E; Santoro A; Ren Y; Ogbu U; Marinello P; Jurczak W
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16)

waveLINE-006: A phase 2 study of the safety and efficacy of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B-cell malignancies.

Zinzani PL; Mayer J; Benjamini O; Berkovits A; Glimelius I; Stevens DA; Chaudhry A; Demir AM; Sanz RG; Kim WS; Li F; Halka J; Marin-Niebla A; Ozcan M; Paszkiewicz-Kozik E; Santoro A; Ren Y; Ogbu U; Marinello P; Jurczak W
Conference publication: JOURNAL OF UROLOGY. 2023;209:E451

THE EARLY RESULTS OF THE SWENOTECA (SWEDISH NORWEGIAN TESTICULAR CANCER GROUP) INTRODUCTION OF PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) IN SEMINOMA STAGE IIA-IIB ≤ 3CM

Thor A; Gerdtsson A; Almas B; Halvorsen D; Cedermark GC; Neegaard H; Glimelius I; Haugnes HS; Karlsdottir A; Stahl O; Larsen SM; Bergdahl AG; Tandstad T; Kjellman A
Conference publication: BLOOD. 2022;140:9411-9412

Treatment-Related Circulatory Diseases and Mortality in Hodgkin Lymphoma Patients Using Multi-State Modelling and Relative Survival

Baech J; Jakobsen LH; El-Galaly TCC; Molin D; Glimelius I; Entrop JPP; Crowther M; Smedby KE; Eloranta S; Weibull CE
Conference publication: BLOOD. 2022;140:1079-1081

Reproduktiv Patterns Among Non-Hodgkin Lymphoma Survivors By Subtype in Sweden, Denmark and Norway

Entrop JPP; Weibull CE; Smedby KE; Jakobsen LH; Oevlisen AK; Glimelius I; Marklund A; Larsen TS; Holte H; Fossa A; Smeland KB; El-Galaly TCC; Eloranta S
Conference publication: BLOOD. 2022;140:184-185

Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial

Jerkeman M; Kolstad A; Hutchings M; Pasanen A; Meriranta L; Niemann CU; Jorgensen RRK; El-Galaly TCC; Riise J; Leppa S; Christensen JH; Wader KF; Glimelius I
Conference publication: ANNALS OF ONCOLOGY. 2022;33(7):S777

Risk and mortality of testicular cancer in patients with psychiatric or neurodevelopmental disorders

Jansson AK; Soderling J; Reutfors J; Thor A; Skold C; Cohn-Cedermark G; Stahl O; Smedby KE; Pettersson A; Glimelius I
Editorial comment: BRITISH JOURNAL OF HAEMATOLOGY. 2022;198(1):11-13

Late relapses in Hodgkin lymphoma - should we search for the needle in the haystack?

El-Galaly TC; Glimelius I
Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2022;97(7):E255-E257

Cardiovascular disease in patients with chronic lymphocytic leukemia: A Swedish nationwide register study with matched comparators.

Larsson K; Söderling J; Höglund M; Glimelius I; Mattsson M
Letter: HAEMATOLOGICA. 2022;107(3):740-743

Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017.

Albertsson-Lindblad A; Palsdottir T; Smedby KE; Weibull CE; Glimelius I; Jerkeman M
Conference publication: CANCER RESEARCH. 2022;82(12)

Spatially resolved multiplexed analysisreveals how macrophages adapt to the mantle cell lymphoma microenvironment

Rodrigues JM; Lokhande L; Gerdtsson A; Nikkarinen A; Hollander P; Porwit A; Glimelius I; Jerkeman M; Ek S
Conference publication: JOURNAL OF UROLOGY. 2022;207(5):E845

PREDICTING THE HISTOPATHOLOGY RESULT OF POST-CHEMO RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND)

Gerdtsson A; Thor A; Bergdahl AG; Negaard H; Almas B; Glimelius I; Karlsdottir A; Halvorsen D; Andreassen KE; Larsen SM; Wahlqvist R; Haugnes HS; Tandstad T; Holmberg G; Cedermark GC; Stahl O; Thorison G; Kjellman A
Letter: HAEMATOLOGICA. 2021;106(9):2502-2506

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma.

Vajavaara H; Ekeblad F; Holte H; Jorgensen J; Leivonen S-K; Berglund M; Kamper P; Moller HJ; D'Amore F; Molin D; Enblad G; Ludvigsen M; Glimelius I; Leppa S
Conference publication: ANNALS OF ONCOLOGY. 2021;32:S748-S749

Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes

Skold C; Koliadi A; Enblad G; Stalberg K; Glimelius I
Conference publication: BLOOD. 2020;136:3-4

Nationwide Investigation of Patient Trajectories in Mantle Cell Lymphoma - Initial Data from the Swedish MCL Complete Project

Jerkeman M; Palsdottir T; Glimelius I; Albertsson-Lindblad A; Weibull C; Ellin F; Sonnevi K; Lewerin C; Brandefors L; Smedby KE
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2020;190(4):e245-e248

High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population-based study.

Larsson K; Mattsson M; Ebrahim F; Glimelius I; Höglund M
Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(2):E36-E38

Increasing prevalence of chronic lymphocytic leukemia with an estimated future rise: A nationwide population-based study.

Mattsson M; Sandin F; Kimby E; Höglund M; Glimelius I
Conference publication: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95:S14-S15

Prognostic Relevance of IL-6 Expression in the Tumor Microenvironment of Classical Hodgkin Lymphoma

Gholiha AR; Hollander P; Hedstrom G; Molin D; Hjalgrim H; Smedby KE; Glimelius I; Hashemi J; Amini R-M; Enblad G
Conference publication: JOURNAL OF UROLOGY. 2020;203:E384

LOCATION AND HISTOLOGY OF RETROPERITONEAL METASTASES IN POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR NON-SEMINOMA GERM CELL TUMOUR

Gerdtsson A; Thor A; Grenabo A; Almas B; Negaard HFS; Glimelius I; Halvorsen D; Karlsdottir A; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Stahl O; Kjellman A
Conference publication: BLOOD. 2019;134:2841

Fertility Rates in Young Hodgkin Lymphoma Survivors: A Danish Nationwide Cohort Study of 769 Patients

Ovlisen AK; Jakobsen LH; Kragholm KH; Hutchings M; Frederiksen H; Kamper P; Eloranta S; Weibull C; Glimelius I; Smedby KEE; Severinsen MT; El-Galaly TCC
Conference publication: BLOOD. 2019;134:4572

Autologous Stem Cell Transplantation in Mantle Cell Lymphoma - Selection Mechanisms and Survival By Age Group

Glimelius I; Smedby KE; Albertsson-Lindblad A; Eloranta S; Jerkeman M; Weibull C
Review: LEUKEMIA & LYMPHOMA. 2019;60(13):3116-3131

Socioeconomic impact of Hodgkin lymphoma in adult patients: a systematic literature review.

Pálmarsdóttir R; Kiesbye Øvlisen A; Severinsen MT; Glimelius I; Smedby KE; El-Galaly T
Conference publication: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019;29:A148-A149

PREGNANCY-RELATED RISK FACTORS FOR SEX CORD-STROMAL TUMORS AND GERM CELL TUMORS IN PAROUS WOMEN: A REGISTRY-BASED STUDY

Skold C; Bjorge T; Ekbom A; Engeland A; Gissler M; Grotmol T; Madanat-Harjuoja L; Ording AG; Trabert B; Tretli S; Troisi R; Sorensen HT; Glimelius I
Preprint: 2019;SSRN Electronic Journal

Comorbidities and Sex Differences in Causes of Death Among Mantle Cell Lymphoma Patients - A Nationwide Population-Based Cohort Study

Glimelius I; Smedby KE; Eloranta S; Jerkeman M; Weibull CE
Conference publication: BLOOD. 2018;132:930

Relapse Risk and Loss in Expectation of Lifetime in Young Classical Hodgkin Lymphoma Patients - a Nordic Lymphoma Group Study of 2,582 Patients

Biccler JL; Glimelius I; Eloranta S; Smeland KB; Brown PDN; Jakobsen LH; Frederiksen H; Jerkeman M; Fossa A; Andersson TML; Holte HJ; Bogsted M; El-Galaly TC; Smedby KE
Conference publication: BLOOD. 2018;132:3120

Continuous Increasing Prevalence of Chronic Lymphocytic Leukemia (CLL) with an Estimated Future Rise-a Nationwide Population-Based Study from Sweden

Mattsson M; Sandin F; Kimby E; Hoglund M; Glimelius I
Conference publication: BLOOD. 2018;132:2891

Prognostic Implications of Specific Comorbidities in Mantle Cell Lymphoma Patients, a Swedish Lymphoma Registry Study

Glimelius I; Smedby KE; Jerkeman M; Eloranta S; Weibull C
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2017;35:tps4593

The ABC-study: A randomized phase III study comparing one course of adjuvant bleomycin, etoposide, and cisplatin (BEP) and one course of carboplatin AUC7 in clinical stage I seminomatous testicular cancer

Tandstad T; Stahl O; Dahl O; Glimelius I; Haugnes HS; Karlsdottir A; Langberg CW; Soderstrom K; Solberg A; Stierner UK; Wall N; Cohn-Cedermark GE
Review: JOURNAL OF INTERNAL MEDICINE. 2017;281(3):247-260

Novel treatment concepts in Hodgkin lymphoma.

Glimelius I; Diepstra A
Conference publication: HAEMATOLOGICA. 2016;101:64-65

HEALTHCARE USE AMONG YOUNG HODGKIN LYMPHOMA SURVIVORS IN THE ERA OF INTENSIFIED CHEMOTHERAPY AND LIMITED RADIOTHERAPY

Eloranta S; Smedby KE; Ekberg S; Chang E; Neovius M; Glimelius I
Conference publication: HAEMATOLOGICA. 2016;101:36

HODGKIN LYMPHOMA IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS-A COMPARATIVE STUDY OF CLINICAL PRESENTATION AND TREATMENT OUTCOME

Englund A; Glimelius I; Rostgaard K; Eloranta S; Molin D; Kuusk T; Brown PDN; Kamper P; Smedby KE; Hjalgrim H; Ljungman G; Hjalgrim LL
Conference publication: HAEMATOLOGICA. 2016;101:3

PROGNOSTIC IMPLICATIONS OF AN ACTIVE, INNATE OR ANERGIC IMMUNE RESPONSE IN THE HODGKIN LYMPHOMA TUMOR MICROENVIRONMENT

Hollander P; Rostgaard K; Smedby KE; Molin D; Loskog A; Brown PDN; Enblad G; Amini R-M; Hjalgrim H; Glimelius I
Conference publication: HAEMATOLOGICA. 2016;101:1-2

HIGH EXPRESSION OF PROGRAMMED CELL DEATH RECEPTOR 1 IN THE TUMOR MICROENVIRONMENT IS ASSOCIATED WITH INFERIOR EVENT FREE SURVIVAL IN CLASSICAL HODGKIN LYMPHOMA

Hollander P; Kamper P; Smedby KE; Enblad G; Mortensen J; Amini R-M; d'Amore F; Molin D; Glimelius I
Conference publication: HAEMATOLOGICA. 2016;101:22

HODGKIN LYMPHOMA IN SWEDEN SINCE 2000: BETTER SURVIVAL ONLY IN ELDERLY WOMEN - A SWEDISH LYMPHOMA REGISTRY STUDY

Wahlin BE; Overgaard N; Peterson S; Digkas E; Glimelius I; Lagerlof I; Johansson A-S; Palma M; Hansson L; Linderoth J; Goldkuhl C; Molin D
Corrigendum: JOURNAL OF CANCER SURVIVORSHIP. 2015;9(4):610-611

Erratum to: Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study.

Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
Letter: LEUKEMIA. 2005;19(12):2360-2362

Angiogenesis and mast cells in Hodgkin lymphoma.

Glimelius I; Edström A; Fischer M; Nilsson G; Sundström C; Molin D; Amini R-M; Enblad G
Visa fler

Anställningar

Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2023-2026

Handledare

Caroline Weibull, Survivorship in Hodgkin lymphoma : childbearing and treatment-related disease, https://openarchive.ki.se/xmlui/handle/10616/46467, 2014

Om mig

Forskningsbeskrivning

Undervisning

Artiklar

Alla övriga publikationer

Anställningar

Handledare

Nyheter från KI

Kalenderhändelser från KI